BRIEF-Oxigene says receives European orphan drug designation for CA4P
 

BRIEF-Oxigene says receives European orphan drug designation for CA4P
* European commission has granted orphan drug designation to CA4P for treatment of gastro-entero-pancreatic neuroendocrine tumors
http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...98:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...98:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/IQfmAZ5-Dz0